Clinical characteristics, healthcare use, and annual costs among patients with dystrophic epidermolysis bullosa
2022 · Orphanet Journal of Rare Diseases · 30 citations
https://doi.org/10.1186/s13023-022-02509-0
B
Benjamin Chastek
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
124
Papers
1.2K
Citations
19
h-index
22
i10-index
Benjamin Chastek is an academic researcher from Optum (United States). The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Biosimilars and Bioanalytical Methods. The author has an h-index of 19, co-authored 106 publications.
ORCID: 0000-0002-9759-6001Papers by this author
worksPersistence in treatment-experienced people with HIV switching anti-retroviral therapy regimens since 2018
2024 · Future Virology · 6 citations
https://doi.org/10.1080/17460794.2024.2403246
Healthcare Resource Utilization and Associated Costs in Patients With Systemic Lupus Erythematosus Diagnosed With Lupus Nephritis
2023 · Cureus · 5 citations
https://doi.org/10.7759/cureus.37839
Relative vaccine effectiveness of MF59-adjuvanted vs high-dose trivalent inactivated influenza vaccines for prevention of test-confirmed influenza hospitalizations during the 2017–2020 influenza seasons
2024 · International Journal of Infectious Diseases · 5 citations
https://doi.org/10.1016/j.ijid.2024.107160
Real-World Adherence to and Persistence with Vibegron in Patients with Overactive Bladder: A Retrospective Claims Analysis
2024 · Advances in Therapy · 2 citations
https://doi.org/10.1007/s12325-024-02824-x
Evaluation of adverse clinical outcomes in patients with inflammatory bowel disease receiving different sequences of first- and second-line biologic treatments: findings from ROTARY
2024 · BMC Gastroenterology · 2 citations
https://doi.org/10.1186/s12876-024-03378-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat